CEACAM6 and cancer: In this study, we only utilized three different cells, namely, hybridoma as the source of the CEACAM6 antibody, PC 3 as a non CEACAM6 susceptible cancer cell line and MDA-MB-468 as a CEACAM6 antibody susceptible cancer cell line (Figure 4A).